Acute lymphoblastic leukaemia, a malignant disorder of lymphoid progenitor cells, affects
both children and adults, with peak prevalence between the ages of 2 and 5 years. Steady …

Major therapeutic progress has been accomplished in leukemia and myelodysplastic
syndrome (MDS) over the past 40 years, which may not be fully appreciated by the larger …

An international collaboration was set up to prospectively evaluate the role of allogeneic
transplantation for adults with acute lymphoblastic leukemia (ALL) and compare autologous …

We examined the prognostic impact of cytogenetics on the outcome of 200 acute
lymphoblastic leukemia (ALL) patients 15 to 65 years of age enrolled in Southwest Oncology …

Allogeneic hematopoietic cell transplantation (HCT) is the only known curative modality for
patients with Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) …

We present here a genome-wide map of abnormalities found in diagnostic samples from 45
adults and adolescents with acute lymphoblastic leukemia (ALL). A 500K SNP array …

Background Secondary acute lymphoblastic leukemia (sALL) is a rare disease and its
biologic features are not well characterized. Patients and methods We describe a cohort of …

We report the retrospective outcomes of unrelated donor (URD) transplants in 169 patients
with acute lymphoblastic leukemia (ALL) in first complete remission (CR1) who received …

The Cancer and Leukemia Group B has performed central review of karyotypes submitted
by institutional cytogenetics laboratories from patients with acute myeloid (AML) and acute …

Allogeneic hematopoietic stem cell transplantation (SCT) has the potential to cure patients
with acute leukemia or myelodysplastic syndromes (MDS), but a number of prognostic …